Sunday, 30 August 2026

FDA clears new drug for rare skin condition
Drug Doses

FDA clears new drug for rare skin condition

The FDA approved Lisraya (brepocitinib) for dermatomyositis, a rare skin condition causing inflammation and muscle weakness, offering targeted treatment.

By Ember Pennington  •  August 28, 2026
Read More



Margaret Murray Critiques Republicans on Medicaid Stance
Diet Links

Margaret Murray Critiques Republicans on Medicaid Stance

Margaret Murray critiques Republicans on Medicaid stance, calling the overhaul's provisions, including work requirements and redetermination cycles, deeply…

By Ember Pennington  •  30/08/2026
AI Tool Forecasts Diabetes Complications
Monitor Picks

AI Tool Forecasts Diabetes Complications

New AI tool forecasts diabetes complications in patients, helping prevent heart disease and kidney disease risks.

By Calloway Fairfax  •  29/08/2026
FDA clears new drug for rare skin condition
Drug Doses

FDA clears new drug for rare skin condition

The FDA approved Lisraya (brepocitinib) for dermatomyositis, a rare skin condition causing inflammation and muscle weakness, offering targeted…

By Ember Pennington  •  28/08/2026
FDA approves first-of-its-kind therapy for metastatic pancreatic cancer
Stress Checks

FDA approves first-of-its-kind therapy for metastatic pancreatic cancer

FDA approves Rasonque, a first-in-class therapy for metastatic pancreatic cancer. Learn about this new targeted treatment.

By Calloway Fairfax  •  27/08/2026
6 Signs You May Benefit from Facial Rejuvenation
Diet Links

6 Signs You May Benefit from Facial Rejuvenation

Most people considering facial rejuvenation describe the same vague feeling: something looks different, but they cannot say exactly…

By Calloway Fairfax  •  27/08/2026
Stem cell donors getting younger and better
Monitor Picks

Stem cell donors getting younger and better

Stem cell donors are getting younger and better, with mismatched unrelated donors showing promising survival rates for adults…

By Calloway Fairfax  •  26/08/2026
Study links early ADHD risk to caregiving approach
BP Trends

Study links early ADHD risk to caregiving approach

A new study reveals how sensitive caregiving in infancy may reduce ADHD risk linked to prenatal inflammation, offering…

By Lyra Ashworth  •  25/08/2026
Anti-inflammatories emerge as new seborrheic dermatitis treatment
BP Trends

Anti-inflammatories emerge as new seborrheic dermatitis treatment

Discover why dermatologists are shifting toward anti-inflammatory seborrheic dermatitis treatment to improve patient outcomes and reduce drug resistance.

By Calloway Fairfax  •  25/08/2026
FDA approves new drug for rare bone disease
Diet Links

FDA approves new drug for rare bone disease

The FDA approves Pasatru, a breakthrough drug for fibrodysplasia ossificans progressiva (FOP), a rare bone disease affecting 900…

By Ember Pennington  •  24/08/2026
Sparsentan Access Guidance for Kidney Disease Patients
Diet Links

Sparsentan Access Guidance for Kidney Disease Patients

Sparsentan access guidance for kidney disease patients with evidence-based coverage criteria and clinical judgment.

By Calloway Fairfax  •  23/08/2026